Merck & Co. Inc. buy BiotechBee
Start price
08.11.22
/
70%
€100.60
Target price
31.01.25
€150.00
Performance (%)
5.77%
End price
05.05.23
€106.40
Summary
This prediction ended on 05.05.23 with a price of €106.40. The BUY prediction by BiotechBee finished with a performance of 5.77%. Dividends of €0.68 are taken into consideration when calculating the performance. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Merck & Co. Inc. | 5.542% | 5.542% | 59.307% | 19.688% |
| iShares Core DAX® | 0.855% | 0.389% | 2.533% | 52.003% |
| iShares Nasdaq 100 | -0.989% | -4.400% | 25.154% | 77.536% |
| iShares Nikkei 225® | -1.781% | -11.216% | 44.398% | 64.676% |
| iShares S&P 500 | 0.057% | 0.778% | 20.953% | 63.009% |
According to BiotechBee what are the pros and cons of Merck & Co. Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by BiotechBee for this prediction
In the thread Merck & Co. Inc. diskutieren
Buy mit Kursziel 150,0